These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 18816773)
1. What is the role of the enteric commensal flora in IBD? Guarner F Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S83-4. PubMed ID: 18816773 [No Abstract] [Full Text] [Related]
2. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558 [TBL] [Abstract][Full Text] [Related]
3. The role of probiotics and antibiotics in regulating mucosal inflammation. Duchmann R Adv Exp Med Biol; 2006; 579():219-26. PubMed ID: 16620021 [TBL] [Abstract][Full Text] [Related]
4. Probiotics and inflammatory bowel diseases. Bai AP; Ouyang Q Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706 [TBL] [Abstract][Full Text] [Related]
5. Review article: Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Sartor RB Aliment Pharmacol Ther; 1997 Dec; 11 Suppl 3():17-22; discussion 22-3. PubMed ID: 9467975 [TBL] [Abstract][Full Text] [Related]
6. Gut flora in health and disease. Guarner F; Malagelada JR Lancet; 2003 Feb; 361(9356):512-9. PubMed ID: 12583961 [TBL] [Abstract][Full Text] [Related]
13. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics. Rioux KP; Madsen KL; Fedorak RN Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308 [No Abstract] [Full Text] [Related]
14. Probiotics in inflammatory bowel disease--therapeutic rationale and role. Shanahan F Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591 [TBL] [Abstract][Full Text] [Related]
15. Role of microecology in chronic inflammatory bowel diseases. Guarner F; Casellas F; Borruel N; Antolín M; Videla S; Vilaseca J; Malagelada JR Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945 [TBL] [Abstract][Full Text] [Related]
17. The role of endogenous bacterial flora: bystander or the necessary prerequisite? Rath HC Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):615-20. PubMed ID: 12840671 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases. Vanderpool C; Yan F; Polk DB Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173 [TBL] [Abstract][Full Text] [Related]
19. Microecology as a target for therapeutic intervention in inflammatory bowel disease. Guarner F IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066 [TBL] [Abstract][Full Text] [Related]
20. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis. Swidsinski A; Loening-Baucke V; Bengmark S; Lochs H; Dörffel Y Inflamm Bowel Dis; 2007 Jan; 13(1):51-6. PubMed ID: 17206639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]